Stockscreener 앱 받기
1.271
3.25%
0.041
전일 마감가:
$1.23
열려 있는:
$1.32
하루 거래량:
3.30M
Relative Volume:
0.86
시가총액:
$282.90M
수익:
$95,000
순이익/손실:
$-327.27M
주가수익비율:
-0.5995
EPS:
-2.12
순현금흐름:
$-239.25M
1주 성능:
-7.97%
1개월 성능:
+12.39%
6개월 성능:
-12.41%
1년 성능:
-52.08%
1일 변동 폭
$1.20
$1.33
1주일 범위
$1.20
$1.53
52주 변동 폭
$0.8621
$3.78
Allogene Therapeutics Inc Stock (ALLO) Company Profile
명칭
Allogene Therapeutics Inc
전화
(650) 457-2700
주소
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALLO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALLO
Allogene Therapeutics Inc
|
1.275 | 272.91M | 95,000 | -327.27M | -239.25M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-05-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-08-08 | 재개 | Oppenheimer | Outperform |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-01-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-01-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-08 | 개시 | Citigroup | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2023-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-06 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-12-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-08-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-15 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-06-03 | 개시 | Robert W. Baird | Neutral |
| 2022-02-28 | 재확인 | B. Riley Securities | Buy |
| 2021-10-20 | 개시 | Cowen | Outperform |
| 2021-10-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-10-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-21 | 재개 | Jefferies | Buy |
| 2021-05-20 | 업그레이드 | Truist | Hold → Buy |
| 2021-05-14 | 개시 | B. Riley Securities | Buy |
| 2021-01-26 | 업그레이드 | Stifel | Hold → Buy |
| 2020-12-10 | 재개 | H.C. Wainwright | Buy |
| 2020-11-24 | 개시 | BofA Securities | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-06-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-05-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-19 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-15 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-05-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-14 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-04-13 | 개시 | SunTrust | Buy |
| 2020-03-13 | 개시 | H.C. Wainwright | Buy |
| 2020-03-05 | 개시 | Stifel | Hold |
| 2020-02-24 | 개시 | Berenberg | Hold |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-11-04 | 개시 | Canaccord Genuity | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-05 | 개시 | ROTH Capital | Neutral |
| 2019-05-31 | 개시 | Guggenheim | Neutral |
| 2019-05-23 | 개시 | Stifel | Hold |
| 2019-03-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Allogene Therapeutics Inc 주식(ALLO)의 최신 뉴스
What to do if you’re stuck in Allogene Therapeutics Inc.2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Allogene Therapeutics Inc. trendsTrade Ideas & Verified Stock Trade Ideas - newser.com
What’s the recovery path for long term holders of Allogene Therapeutics Inc.July 2025 Review & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-10 09:33:16 - newser.com
Applying sector rotation models to Allogene Therapeutics Inc.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Is Allogene Therapeutics Inc. stock poised for growth2025 Price Targets & Technical Pattern Based Buy Signals - newser.com
Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha
JP Morgan Downgrades Allogene Therapeutics (ALLO) to Underweight - GuruFocus
JPMorgan Downgrades Allogene Therapeutics to Underweight From Neutral - MarketScreener
What technical models suggest about Allogene Therapeutics Inc.’s comebackWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Allogene Therapeutics Inc. stock volume spike explainedMarket Growth Report & Real-Time Volume Analysis - newser.com
Allogene Therapeutics' (ALLO) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
What analysts say about Allogene Therapeutics Inc stockFundamental Stock Analysis & Free Triple Digit Wealth Increase - earlytimes.in
Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus - MSN
Measuring Allogene Therapeutics Inc.’s beta against major indicesCEO Change & Consistent Profit Trade Alerts - newser.com
What does recent volatility data suggest for Allogene Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Guides - newser.com
What indicators show strength in Allogene Therapeutics Inc.Weekly Profit Report & Fast Moving Market Watchlists - newser.com
Market reaction to Allogene Therapeutics Inc.’s recent newsMarket Weekly Review & AI Driven Price Predictions - newser.com
Published on: 2025-10-05 03:06:55 - newser.com
Allogene Therapeutics (NASDAQ:ALLO) Rating Increased to Hold at Wall Street Zen - MarketBeat
Allogene Therapeutics at Citi’s SMID Call Series: Strategic Insights By Investing.com - Investing.com Canada
Published on: 2025-10-03 05:33:11 - newser.com
Applying big data sentiment scoring on Allogene Therapeutics Inc.Short Setup & Capital Efficient Trade Techniques - newser.com
Published on: 2025-10-02 20:30:24 - newser.com
Published on: 2025-10-01 08:38:29 - newser.com
Analyzing net buyer seller activity in Allogene Therapeutics Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Published on: 2025-09-29 14:28:46 - newser.com
Published on: 2025-09-29 11:38:34 - newser.com
Published on: 2025-09-29 07:57:40 - newser.com
Will Allogene Therapeutics Inc. stock beat EPS estimatesJuly 2025 Selloffs & Smart Allocation Stock Reports - The British Mountaineering Council
344,880 Shares in Allogene Therapeutics, Inc. $ALLO Purchased by Kingstone Capital Partners Texas LLC - MarketBeat
Real time scanner hits for Allogene Therapeutics Inc. explained2025 Technical Overview & Weekly High Return Forecasts - newser.com
Profit Recap: Can Allogene Therapeutics Inc. be the next market leaderPortfolio Performance Summary & AI Forecasted Stock Moves - khodrobank.com
Will Allogene Therapeutics Inc stock hit new highs in YEAR2025 Fundamental Recap & Reliable Breakout Forecasts - khodrobank.com
Custom watchlist performance reports with Allogene Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Update Report: Will Allogene Therapeutics Inc benefit from geopolitical trends2025 Market Sentiment & AI Driven Price Predictions - khodrobank.com
Allogene Therapeutics (NASDAQ:ALLO) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Using fundamentals and technicals on Allogene Therapeutics Inc.Portfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Aug PostEarnings: Can Allogene Therapeutics Inc reach resistance levels soonJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک
History Review: Will Allogene Therapeutics Inc benefit from geopolitical trendsDip Buying & Weekly Momentum Stock Picks - خودرو بانک
Aug Reactions: What are the risks of holding Allogene Therapeutics Inc2025 Volume Leaders & Weekly Momentum Stock Picks - خودرو بانک
Bearish Setup: Will Allogene Therapeutics Inc stock hit new highs in YEAR2025 Price Momentum & Daily Oversold Bounce Ideas - خودرو بانک
Gainers Report: Will Allogene Therapeutics Inc outperform the market in YEAR2025 Macro Impact & Verified Entry Point Detection - خودرو بانک
Allogene Therapeutics Inc (ALLO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
자본화:
|
볼륨(24시간):